Faculty Bibliography

Purpose : The lamina cribrosa (LC) is considered to play an important role in the pathogenesis of glaucoma. In this study, we investigate the shape variation (SV) of the LC pores as a potential biomarker for quantifying the morphological irregularity in vivo. Methods : 36 healthy and 14 glaucomatous (GL) eyes (total: 39 subjects) underwent a comprehensive ophthalmic examination and scanning of the optic nerve head with sweptsource OCT (Table 1). Images were converted to isotropic and pores were segmented using ImageJ. SV was defined as the mean-squared error of the pore pattern with respect to a solid circle (Figure 1(a)) with SV of a circle marked as zero, and higher SV value with increasing shape irregularity. SV of each pore was automatically calculated by a MATLAB code. The overall SV value was generated as the average of SV in the stack of individual slices. Age effect on SV was examined in all healthy eyes and a subset of 14 eyes was selected for age-matched comparison with the glaucomatous eyes (Table 1). Results : No significant correlation was detected between SV and age (p=0.145; Spearman correlation) in all healthy subjects. Examining the effect of depth on the difference between SV of glaucomatous and healthy eyes, the posterior third of the LC had significantly lower than other sections (p=0.007; Figure 1(b)). SV in glaucoma eyes was significantly higher than in the healthy group (p=0.008; Figure 1(c)). Conclusions : We demonstrated morphological differences in pore shape variation between healthy and glaucoma eyes that is mostly affecting the anterior 2/3 of the LC. Further studies are warranted to assess the use of SV as a structural biomarker in glaucoma

Purpose : To assess the repeatability of estimates of mean deviation (MD) and visual field index (VFI) obtained from an automated deep-learning approach that analysed raw OCT volumes. Methods : OCT scans were acquired from both eyes of 138 healthy, 743 glaucoma suspects and 941 glaucoma patients (Cirrus HD-OCT scanner, 200x200 ONH Cubes, Zeiss, Dublin CA). The scans were acquired at multiple visits, with two or more scans acquired at each visit. Scans with signal strength < 7 were discarded, giving us a total of 19,208 OCT scans. A subset of 5207 eyes (total of 10,414 scans) had repeat scans of that met the inclusion criteria. 24-2 Humphrey visual field (VF) tests were administered at each visit. A single convolutional neural network was trained to estimate the MD and VFI (dual outputs) from downsampled OCT volumes (50x50x128 voxels). The network consisted of 5 convolutional layers, followed by a global average pooling layer and dual outputs to enable the simultaneous estimation of MD and VFI. A mean squared error loss was used to train the network using an Adam optimiser over a total of 200 epochs. A 10-fold cross-validation scheme was used, where the dataset was divided into 10 non-overlapping folds (~182 subjects per fold) - trained on 8-folds, validated on one and tested on one. Each subject was limited to a unique fold. The performance of the method was assessed by computing the median error and interquartile range. The repeatability was assessed using a set of 5207 OCT scans that had repeats available. Results : The median absolute error (Q1, Q3) for the estimates of MD and VFI were 1.66 (0.79, 2.99) dB and 3.01 (1.48, 6.63) %, respectively. In the reproducibility test, the Pearson's correlation coefficient was 0.91 (CI: [0.91, 0.92]) and 0.91 (CI: [0.90, 0.92]), for MD and VFI, respectively. The median absolute difference between the repeated estimates for MD and VFI were 0.53 (0.21, 0.51) dB and 1.17 (0.45, 1.14)%, respectively. Conclusions : The deep-learning based approach for estimating visual field test parameters shows repeatability better than expected test-to-test variability

Purpose : Current Optical Coherence Tomography (OCT) denoising techniques mainly focus on denoising 2-dimensional (2D) B-scans, especially for deep learning (DL) methods, which assume spatial integrity among neighboring samplings. However, OCT signal is essentially one dimensional (1D), and eye movements during scanning often violate the assumption. The purpose of this study was to see if 1D denoising is a feasible approach for clinical OCT imaging. Methods : 3D SD-OCT data within 6x6x2mm volumes centered on optic nerve head were obtained from 121 eyes (79 patients). Clean reference scans were constructed by registering and averaging 6 OCT scans obtained on the same day using ANTs software. As shown in Figure 1, we used a 5-layer U-shape net (UNet) for both 2D denoiser (Figure 1.(a)) and 1D denoiser (Figure1.(b)). In addition, both 2D and 1D approaches are combined by using the 2D denoised B-scan as a mask to selectively remove high signal peaks in the 1D denoised B-scan (Figure 1.(c)). Peak signal-to-noise ratio (PSNR) and contrast-to-noise ratio (CNR) were calculated to compare the performance. Results : Subjectively, the 2D denoiser generated smoother edges but tended to oversmooth textual information within the retinal layers, while the 1D denoiser preserved more textual information but caused more jittering at retinal edges due to the lack of structural information from neighboring A-scans. Quantitatively, the 1D denoiser showed similar PSNR to the 2D denoiser, while outperforming in CNR (PSNR: 31.20 (1D) V.S. 31.20 dB (2D), p=0.963; CNR: 4.23 (1D) V.S. 3.90 dB (2D), p<0.001, paired t-test, Table 1). The combined denoiser further improved CNR (4.39 (combined) V.S. 3.90 dB (2D), p<0.001). Combining 1D and 2D denoisers, the denoised B-scan showed more continuous edges compared to the 1D denoiser and did not lose the texture information compared to the 2D denoiser (Figure 2). Conclusions : Quantitatively, 1D denoiser performance is as good as 2D denoiser or even better. A combination of 1D and 2D approaches may provide well-balanced image enhancement in clinical applications

Purpose : Repetitive transorbital alternating current stimulation (rtACS) is an application of weak electric current near the eyes used in vision rehabilitation of optic neuropathies (ON). Conceptually rtACS entrains neuronal oscillations, augmenting neuronal function. In subjects with ON we evaluated whether rtACS influenced visual structure and function. Methods : 34 subjects with ON enrolled in a prospective trial underwent comprehensive ophthalmic evaluation, visual field (VF) 24-2 and 10-2 tests (Humphrey Field Analyzer) and OCT (Cirrus HD-OCT) retinal nerve fiber layer (RNFL) and ganglion cell inner plexiform layer (GCIPL) thicknesses at baseline and follow-up (FU) visits. Subjects received rtACS 30-to 45-minutes daily for 10 days. Sham subjects (n=4) underwent the same procedures but received no current. Point-by-point analyses of VF total deviation (TD) values were conducted between rtACS and sham groups. Regression analyses determined rate of change for each TD point per eye (significant points with positive rate of change defined as improved, negative rate of change as progressed; insignificant rate of change as no change) and the association between RNFL and GCIPL between groups. Results : The number of FU visits with VF tests ranged 2 to 7, with no significant differences detected between rtACS vs sham groups' FU duration. No significant differences were detected between groups' baseline VF 24-2 and 10-2 mean deviation (MD) values (Table 1). The average numbers of improved points (VF 10-2) and progressed points (VF 24-2) were greater for rtACS while the average number of no change points was greater for sham (VF 24-2, p0.05, Table 1). Further analysis of FU duration determined a significant interaction with rtACS; number of improved points (VF 10-2) and progressed points (VF 24-2, p<0.02) were not sustained over time. No significant differences were detected in average RNFL and GCIPL thicknesses between groups. Conclusions : Preliminary analyses of the effect of rtACS in ON indicate initial improvement but not a clear benefit over time. Detection of differences between rtACS vs sham groups may be biased due to the small sham sample and range of FU duration as VF test-to-test variability is known to increase with worsening VF MD. Future analyses will assess interim effect at early vs late FU time points to evaluate the role of rtACS in vision rehabilitation

Purpose : Intraocular pressure (IOP) is currently the only modifiable risk factor for glaucoma, yet glaucoma can continue to progress despite controlled IOP. Thus, development of glaucoma neurotherapeutics remains an unmet need. Scutellarin is a flavonoid that exhibits a number of neuroprotective effects on the brain and the eye. Here, we investigated the neurobehavioral effects of oral scutellarin treatment in a novel experimental model of chronic glaucoma. Methods : Ten adult C57BL/6J mice (Group 1) were unilaterally injected with an optically clear hydrogel into the anterior chamber to obstruct aqueous outflow and induce chronic IOP elevation. Eight other mice (Group 2) received a unilateral intracameral injection of phosphate-buffered saline only. Another eight mice (Group 3) with hydrogel-induced unilateral chronic IOP elevation also received daily oral gavage of 300 mg/kg scutellarin from 1 week before to 2 weeks after hydrogel injection. Tonometry, optical coherence tomography, and optokinetic visuobehavioral testing were performed longitudinally to monitor the IOP, total retinal thickness, visual acuity, and contrast threshold of bilateral eyes in all three groups. Results : Intracameral hydrogel injection resulted in unilateral chronic IOP elevation with no significant IOP difference between scutellarin treatment and untreated groups (Figure site uses cookies. By continuing to use our website, you are agreeing to 1). With scutellarin treatment, the hydrogel-injected eyes showed less retinal thinning and reduced visual behavioral deficits when compared to the untreated, hydrogel-injected eyes (Figure 2). No significant difference in retinal thickness or optokinetic measures was found in the non-injected eyes over time or between all groups. Conclusions : Oral scutellarin treatment appeared to preserve retinal structure and visual function in experimental glaucoma induced by chronic IOP elevation. Scutellarin may be a possible candidate as a novel neurotherapeutic agent for glaucoma treatment

Purpose : Mutations in optineurin (OPTN) are associated with familial normal tension glaucoma and other neurodegenerative diseases. It remains unclear how OPTN loss or mutation alters visual function during aging. Here, we used transgenic mouse models and in vivo assessments to test the hypothesis that OPTN dysfunction contributes to progressive visual impairment through a toxic gain of function mechanism. Methods : Mice with C57BL/6 background were used (Fig 1): wildtype (WT; n=19), homozygous OPTN knock-out (mOPTN-KO; n=13), hemizygous mouse E50K OPTN knock-in (mE50K-het; n=8), homozygous mouse E50K OPTN knock-in (mE50K homoz; n=10), and human E50K OPTN bacterial artificial chromosome overexpression (hE50K BAC; n=6) (PMID: 31076632, 25818176). Intraocular pressure (IOP), total retinal thickness (TRT), visual acuity (VA), and contrast sensitivity (CS) were measured at 6, 12, and 18 months of age in the same mice using the TonoLab rebound tonometer, Bioptigen spectral-domain optical te uses cookies. By continuing to use our website, you are agreeing to coherence tomography imaging, and OptoMotry optokinetic virtual reality system respectively. Left and right eye data were averaged and analyzed using ANOVAs followed by posthoc tests between genotype and age groups, as well as linear regressions for VA versus contrast threshold (CT). Results : Our longitudinal study of the same mice during the aging process showed that IOP remained normal between 10-15 mmHg (Fig 2A). Small to no difference in TRT over time or compared to WT was observed (Fig 2B). mE50K-homoz, mE50K-het, and hE50K BAC mice exhibited greater age-dependent decline in VA and CT than WT or mOPTN-KO mice (Fig 2C, 2D, 2E). In contrast, mOPTN-KO mice showed preservation of VA and CT over time compared to WT. Consistently, mice with one copy of E50K OPTN (mE50K het) experienced less deterioration of VA and CT compared to mice with two copies (mE50K homoz) or mild overexpression (hE50K BAC). Conclusions : Depsite limited IOP and TRT changes between age and genotype groups, E50K OPTN was associated with differential age-dependent visual impairment (greater for CS than VA). Surprisingly, OPTN deficiency preserved visual function such that CS in knockout mice was better than WT mice. Our results suggest visual loss associated with E50K OPTN is due to a toxic gain of function mechanism, and that suppression of OPTN might constitute a therapeutic strategy for glaucomatous neurodegeneration

Purpose : Lamina cribrosa (LC) deformation is hypothesized to be a major cause of glaucoma. The LC undergoes different forms of stress both anteriorly from intraocular pressure (IOP), as well as posteriorly and circumferentially from subarachnoid cerebrospinal fluid pressure (CSFP) and the sclera. The purpose of this study was to determine possible in vivo changes in the path of the lamina pores under different IOP settings while maintaining fixed CSFP. Methods : Spectral-domain OCT scans (Leica, Chicago, IL) of the optic nerve head (ONH) were acquired in vivo under different pressure settings from healthy rhesus monkeys. IOP was controlled using a gravity-based perfusion system through a needle inserted into the anterior chamber. CSFP was maintained at the baseline opening pressure via gravitybased perfusion system through cannulation of the brain's lateral ventricle (range 8- 12mmHg). Scans were acquired at baseline IOP (15mmHg), high (30 mmHg) and very high IOP (40-50 mmHg) and registered in 3D. Pores from shared regions were automatically segmented using a previously described segmentation algorithm. The path of each pore was tracked based on the calculated geometric centroid of each pore. The tortuosity of each pore path was defined as the total actual distance of the centroid path divided by the minimal distance between the first (most anterior) and last (most posterior) pore centroids. Results : 7 eyes from 6 healthy adult Rhesus macaque were analyzed. The mean value of the pore path tortuosity varies between eyes at baseline IOP levels (range: 1.16-1.68; Table). Two main overall patterns of pore path tortuosity were detected in response to increased IOP at fixed CSFP: 4 eyes became more tortuous (M2, M5, M8, M11); in the rest of the eyes (M6 OD, M6 OS, M10) the pore paths remained either unchanged or showed a variable response. No statistically significant change (p > 0.05) was observed in this small sample in either the subject-specific analysis or the analysis of the pooled combined values of the pore path tortuosity. Conclusions : Baseline pore tortuosity as well as the response of the pores to acute IOP increase varies between eyes. Further investigation is warranted to determine if these differences are associated with glaucoma susceptibility

PURPOSE/OBJECTIVE:To describe the efficacy and safety of open versus closed conjunctival implantation of the XEN45 Gel Stent (Allergan Inc). DESIGN/METHODS:Retrospective, multicenter study. PARTICIPANTS/METHODS:A total of 137 patients with glaucoma who underwent XEN45 implantation via open or closed conjunctival methods. The XEN45 was implanted as a stand-alone procedure or at the time of cataract surgery by 5 surgeons. METHODS:Patient demographics, diagnoses, preoperative and postoperative clinical data, outcome measures including intraocular pressure (IOP), use of glaucoma medications, visual acuity, and complications were collected. Statistical analyses were performed with P < 0.05 as significant. MAIN OUTCOME MEASURES/METHODS:Failure was defined as less than 20% reduction of IOP from medicated baseline or IOP >21 mmHg at 2 consecutive visits at postoperative month 1 and beyond, the need for subsequent operative intervention or additional glaucoma surgery, or a catastrophic event such as loss of light perception. Eyes that had not failed by these criteria and were not on glaucoma medications were considered complete successes. Eyes that had not failed but required glaucoma medications were defined as qualified successes. RESULTS:Complete success was achieved in 31% and 56% of the closed and open groups, respectively (P = 0.01). Qualified success was achieved in 53% and 71% of the closed and open groups, respectively (P = 0.06). At postoperative month 12, the open conjunctiva group was using fewer glaucoma medications than the closed group (0.9 vs. 1.8, respectively; P = 0.02). At postoperative month 12, the open group had a significantly greater percentage of IOP reduction compared with the closed group (43.1% vs. 24.8%, respectively; P = 0.02). Postoperative needling rates were higher in the closed group compared with the open group (36.1% vs. 11.8%, P = 0.001). CONCLUSIONS:Implantation of the XEN45 with opening of the conjunctiva is a safe and efficacious procedure to lower IOP with comparable success rate and lower needling rate compared with the closed conjunctiva technique. Prospective evaluation of the various methods for XEN45 implantation will allow for further comparison.